Zylö Therapeutics
PrivateLast Round
Grant
May 31, 2023
Total Funding Raised
$13M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Zylö Therapeutics is a biotechnology company developing a topical delivery system using engineered amorphous silica particles to encapsulate compounds for sustained release.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zylö Therapeutics Comparables
Compare Zylö Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Atticus Pharma | 81% | |
| Emissary Cosmetics | 79% | |
| Dermaliq Therapeutics, Inc. | 75% |
Zylö Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 31, 2023 | ||||
| Grant | Aug 19, 2022 | ||||
| Series B | Jun 4, 2022 | ||||
| VC Round | Dec 7, 2021 | ||||
| Series A | Sep 21, 2019 |
Zylö Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Arthritis and Musculoskeletal and Skin Diseases | Grant |
| National Institute of Allergy and Infectious Diseases | Grant |
| United States Department of Defense | Grant |
| Chemical Angel Network | Series A |
| Ariel Savannah Angel Partners | Series A |
| SC Launch | Series A, VC Round, Series B |
| Harvard Business School Alumni Angels of Greater New York | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 87% MoM.
- May 12, 2026
Monthly visitors increased 70% MoM.
Zylö Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Zylö Therapeutics's valuation, stock price, and market status.
Is Zylö Therapeutics a public or private company?
Zylö Therapeutics is a private company.
What is the current stock price of Zylö Therapeutics?
Zylö Therapeutics is a private company, so its shares have no public market price. Caplight tracks Zylö Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Zylö Therapeutics worth (valuation)?
Valuation information for Zylö Therapeutics is not publicly available.
Can I buy Zylö Therapeutics stock?
Zylö Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Zylö Therapeutics's last funding round?
Zylö Therapeutics's most recent funding round was Grant on May 31, 2023.
Who are the main investors in Zylö Therapeutics?
Key investors in Zylö Therapeutics include VentureSouth.
Will Zylö Therapeutics IPO soon?
No public IPO plans have been announced for Zylö Therapeutics.
How can I track Zylö Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Zylö Therapeutics's shares on secondary markets.